EHD1 confers resistance to cisplatin in non-small cell lung cancer by regulating intracellular cisplatin concentrations

Table 1 Clinical characteristics of the NSCLC patients stratified by EHD1 level

Characteristic	Positive	Negative	P
Age (years)
High (≥60)	9	14	0.306
Low (<60)	19	17
Sex
Male	13	25	0.006
Female	15	6
Histology
Adenocarcinoma	26	17	0.001
Squamous cell carcinoma	2	14
Smoking status
Smokers	15	24	0.053
Non smokers	13	7
Differentiation
Well/Moderate	13	12	0.549
Poor	15	19
Stage (AJCC)
I,II	19	26	0.149
III,IV	9	5

ISSN: 1471-2407